Bioinformatics Assessment of β-Myosin Mutations Reveals Myosin's High Sensitivity to Mutations

Trends in Cardiovascular Medicine

Volumn 18, Issue 4, 2008, Pages 141-149

  Buvoli, Massimo ^a   Hamady, Micah ^b   Leinwand, Leslie A ^a   Knight, Rob ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b University of Colorado at Boulder   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA MYOSIN; MYOSIN;

AMINO ACID SUBSTITUTION; BIOINFORMATICS; GENE MUTATION; GENE SEQUENCE; GENE STRUCTURE; MEDICAL INSTRUMENTATION; MISSENSE MUTATION; MUTATIONAL ANALYSIS; NONSENSE MUTATION; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN DOMAIN; REVIEW; SENSITIVITY ANALYSIS; WILD TYPE;

CARDIAC MYOSINS; CARDIOMYOPATHIES; COMPUTATIONAL BIOLOGY; DATABASES, GENETIC; DNA MUTATIONAL ANALYSIS; GENETIC PREDISPOSITION TO DISEASE; GENOMICS; HUMANS; MUSCULAR DISEASES; MUTATION; MYOSIN HEAVY CHAINS; PROTEIN CONFORMATION; PROTEIN STRUCTURE, TERTIARY;

EID: 44849134159     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcm.2008.04.001     Document Type: Review

References (39)

1. Andersen P.S., Havndrup O., Bundgaard H., et al. Myosin light chain mutations in familial hypertrophic cardiomyopathy: phenotypic presentation and frequency in Danish and South African populations. J Med Genet 38 (2001) E43
2. Arad M., Penas-Lado M., Monserrat L., et al. Gene mutations in apical hypertrophic cardiomyopathy. Circulation 112 (2005) 2805-2811
3. Blair E., Redwood C., De Jesus Oliveira M., et al. Mutations of the light meromyosin domain of the beta-myosin heavy chain rod in hypertrophic cardiomyopathy. Circ Res 90 (2002) 263-269
4. Blankenfeldt W., Thoma N.H., Wray J.S., et al. Crystal structures of human cardiac beta-myosin II S2-Delta provide insight into the functional role of the S2 subfragment. Proc Natl Acad Sci U S A 103 (2006) 17713-17717
5. Bohlega S., Abu-Amero S.N., Wakil S.M., et al. Mutation of the slow myosin heavy chain rod domain underlies hyaline body myopathy. Neurology 62 (2004) 1518-1521
6. Bos J.M., Ommen S.R., and Ackerman M.J. Genetics of hypertrophic cardiomyopathy: one, two, or more diseases?. Curr Opin Cardiol 22 (2007) 193-199
7. Chang A.N., and Potter J.D. Sarcomeric protein mutations in dilated cardiomyopathy. Heart Fail Rev 10 (2005) 225-235
8. Daehmlow S., Erdmann J., Knueppel T., et al. Novel mutations in sarcomeric protein genes in dilated cardiomyopathy. Biochem Biophys Res Commun 298 (2002) 116-120
9. Davis J.S., Hassanzadeh S., Winitsky S., et al. The overall pattern of cardiac contraction depends on a spatial gradient of myosin regulatory light chain phosphorylation. Cell 107 (2001) 631-641
10. Daw E.W., Chen S.N., Czernuszewicz G., et al. Genome-wide mapping of modifier chromosomal loci for human hypertrophic cardiomyopathy. Hum Mol Genet 16 (2007) 3463-3471
11. Dye D.E., Azzarelli B., Goebel H.H., and Laing N.G. Novel slow-skeletal myosin (MYH7) mutation in the original myosin storage myopathy kindred. Neuromuscul Disord 16 (2006) 357-360
12. Erdmann J., Daehmlow S., Wischke S., et al. Mutation spectrum in a large cohort of unrelated consecutive patients with hypertrophic cardiomyopathy. Clin Genet 64 (2003) 339-349
13. Gerstein M., Sonnhammer E.L., and Chothia C. Volume changes in protein evolution. J Mol Biol 236 (1994) 1067-1078
14. Girolami F., Olivotto I., Passerini I., et al. A molecular screening strategy based on beta-myosin heavy chain, cardiac myosin binding protein C and troponin T genes in Italian patients with hypertrophic cardiomyopathy. J Cardiovasc Med (Hagerstown) 7 (2006) 601-607
15. Havndrup O., Bundgaard H., Andersen P.S., et al. Outcome of clinical versus genetic family screening in hypertrophic cardiomyopathy with focus on cardiac beta-myosin gene mutations. Cardiovasc Res 57 (2003) 347-357
16. Hougs L., Havndrup O., Bundgaard H., et al. One third of Danish hypertrophic cardiomyopathy patients with MYH7 mutations have mutations [corrected] in MYH7 rod region. Eur J Hum Genet 13 (2005) 161-165
17. Kamisago M., Sharma S.D., DePalma S.R., et al. Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. N Engl J Med 343 (2000) 1688-1696
18. Karkkainen S., Helio T., Jaaskelainen P., et al. Two novel mutations in the beta-myosin heavy chain gene associated with dilated cardiomyopathy. Eur J Heart Fail 6 (2004) 861-868
19. Kimura M. Model of effectively neutral mutations in which selective constraint is incorporated. Proc Natl Acad Sci U S A 76 (1979) 3440-3444
20. Kondrashov A.S., Sunyaev S., and Kondrashov F.A. Dobzhansky-Muller incompatibilities in protein evolution. Proc Natl Acad Sci U S A 99 (2002) 14878-14883
21. Korn E.D. Coevolution of head, neck, and tail domains of myosin heavy chains. Proc Natl Acad Sci U S A 97 (2000) 12559-12564
22. Laing N.G., and Nowak K.J. When contractile proteins go bad: the sarcomere and skeletal muscle disease. Bioessays 27 (2005) 809-822
23. Li Y., Brown J.H., Reshetnikova L., et al. Visualization of an unstable coiled coil from the scallop myosin rod. Nature 424 (2003) 341-345
24. Liu X., Shu S., Yamashita R.A., et al. Chimeras of Dictyostelium myosin II head and neck domains with Acanthamoeba or chicken smooth muscle myosin II tail domain have greatly increased and unregulated actin-dependent MgATPase activity. Proc Natl Acad Sci U S A 97 (2000) 12553-12558
25. Lu R.C., and Wong A. The amino acid sequence and stability predictions of the hinge region in myosin subfragment 2. J Biol Chem 260 (1985) 3456-3461
26. Marian A.J., and Roberts R. The molecular genetic basis for hypertrophic cardiomyopathy. J Mol Cell Cardiol 33 (2001) 655-670
27. McLachlan A.D., and Karn J. Periodic charge distributions in the myosin rod amino acid sequence match cross-bridge spacings in muscle. Nature 299 (1982) 226-231
28. Meredith C., Herrmann R., Parry C., et al. Mutations in the slow skeletal muscle fiber myosin heavy chain gene (MYH7) cause Laing early-onset distal myopathy (MPD1). Am J Hum Genet 75 (2004) 703-708
29. Oldfors A. Hereditary myosin myopathies. Neuromuscul Disord 17 (2007) 355-367
30. Richard P., Charron P., Carrier L., et al. Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation 107 (2003) 2227-2232
31. Root D.D., Yadavalli V.K., Forbes J.G., et al. Coiled-coil nanomechanics and uncoiling and unfolding of the superhelix and alpha-helices of myosin. Biophys J 90 (2006) 2852-2866
32. Shannon M. (1948). A mathematical theory of communication. Bell System Tech J 27:379-423, 623-656.
33. Tajsharghi H., Thornell L.E., Lindberg C., et al. Myosin storage myopathy associated with a heterozygous missense mutation in MYH7. Ann Neurol 54 (2003) 494-500
34. Tajsharghi H., Oldfors A., Macleod D.P., and Swash M. Homozygous mutation in MYH7 in myosin storage myopathy and cardiomyopathy. Neurology 68 (2007) 962
35. Tardiff J.C. Sarcomeric proteins and familial hypertrophic cardiomyopathy: linking mutations in structural proteins to complex cardiovascular phenotypes. Heart Fail Rev 10 (2005) 237-248
36. Tsoutsman T., Lam L., and Semsarian C. Genes, calcium and modifying factors in hypertrophic cardiomyopathy. Clin Exp Pharmacol Physiol 33 (2006) 139-145
37. Van Driest S.L., Jaeger M.A., Ommen S.R., et al. Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 44 (2004) 602-610
38. Villard E., Duboscq-Bidot L., Charron P., et al. Mutation screening in dilated cardiomyopathy: prominent role of the beta myosin heavy chain gene. Eur Heart J 26 (2005) 794-803
39. Woo A., Rakowski H., Liew J.C., et al. Mutations of the beta myosin heavy chain gene in hypertrophic cardiomyopathy: critical functional sites determine prognosis. Heart 89 (2003) 1179-1185